Support accounting analyses related to business combinations, asset acquisitions, IPR&D assets, licensing and collaboration arrangements, equity compensation, earnings per share, contingent consideration arrangements, and foreign currency and derivative transactions. Our revolutionary treatments for conditions like achondroplasia (the most common form of dwarfism), PKU (phenylketonuria), CLN2, a form of Batten disease, and a number of forms of MPS (mucopolysaccharidosis) offer new possibilities for patients and families who previously had few, if any, available options.